Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)
South Korea · Delayed Price · Currency is KRW 167,500
-71,500 (-29.92%)
Jul 21, 2026, 2:40 PM KST
Sam Chun Dang Pharm. Market Cap
Sam Chun Dang Pharm. has a market cap or net worth of 5.59 trillion as of July 20, 2026. Its market cap has increased by 44.90% in one year.
Market Cap
5.59T
Enterprise Value
5.63T
Revenue
246.05B
Ranking
n/a
PE Ratio
546.75
Stock Price
167,500.00
ChartMarket Cap Chart
Since September 11, 2001, Sam Chun Dang Pharm.'s market cap has increased from 3.32B to 5.59T, an increase of 168,405.61%. That is a compound annual growth rate of 34.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 4.31T | -20.31% |
| Dec 30, 2025 | 5.41T | 56.57% |
| Dec 30, 2024 | 3.45T | 96.33% |
| Dec 28, 2023 | 1.76T | 82.00% |
| Dec 29, 2022 | 966.58B | 1.04% |
| Dec 30, 2021 | 956.65B | -47.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.62T |
| Celltrion | 40.32T |
| ALTEOGEN | 14.81T |
| Samsung Epis Holdings | 9.85T |
| Yuhan | 5.28T |
| Kolon TissueGene | 5.28T |
| Hanmi Pharm. | 4.90T |
| HLB Co., Ltd. | 4.69T |